Cowen analyst Phil Nadeau raised the price target on Immunomedics (NASDAQ: IMMU) to $55.00 (from $45.00) while maintaining an Outperform ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE